Open Access
Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy
CirculationDennis M. McNamara +112001Journals
This prospective placebo-controlled trial was designed to determine whether intravenous immune globulin (IVIG) improves left ventricular ejection fraction (LVEF) in adults with recent onset of idiopathic dilated cardiomyopathy or myocarditis.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support